Pricing Log in Create free account

Caribou Biosciences, Inc. (CRBU) vs Werewolf Therapeutics, Inc. (HOWL)

Caribou Biosciences, Inc. and Werewolf Therapeutics, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and Werewolf Therapeutics, Inc. are of similar size ($49.8M and $48.5M). Caribou Biosciences, Inc. grew revenue faster over the last twelve months: 10.0% against −5.21%. Werewolf Therapeutics, Inc. has the higher net margin (−141.9% vs −1,030.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Caribou Biosciences, Inc. leads on 7 and Werewolf Therapeutics, Inc. on 7.

Valuation

Metric CRBU HOWL Biotechnology median
P/E n/m n/m 8.50
P/S 4.73 1.95 9.71
P/B 0.48 2.92 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.60 n/m 0.64
EV/Sales (6.46) 1.94 9.21
Earnings yield (229.79%) (74.49%) (33.15%)
Free cash flow yield (279.78%) (62.73%) (25.50%)

Profitability

Metric CRBU HOWL Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (1,090.90%) (128.18%) 0.00%
Net margin (1,030.42%) (141.94%) 0.00%
Free cash flow margin (1,323.30%) (122.51%) 0.00%
Return on equity (78.27%) (119.86%) (56.36%)
Return on assets (56.87%) (59.31%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBU HOWL Biotechnology median
Revenue growth (TTM) 10.02% (5.21%) 6.02%
EPS growth (last fiscal year) 3.64% 18.40% 30.26%
Revenue growth, 5-year CAGR (2.03%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU HOWL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.49 2.91 4.72
Net debt to EBITDA 0.96 0.97 0.96

Dividend

Metric CRBU HOWL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRBU HOWL Biotechnology median
Market cap 49.82m 48.46m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack